The Challenge of Overcoming Antibiotic Resistance: An Adjuvant Approach?

ACS Infectious Diseases

Volumn 3, Issue 8, 2017, Pages 559-563

  Melander, Roberta J ^a   Melander, Christian ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; PHARMACEUTICAL VEHICLES AND ADDITIVES;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; COMBINATION DRUG THERAPY; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; ANIMAL; DRUG EFFECTS; DRUG INTERACTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY;

ADJUVANTS, PHARMACEUTIC; ANIMALS; ANTI-BACTERIAL AGENTS; DRUG INTERACTIONS; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS;

EID: 85027284569     PISSN: None     EISSN: 23738227     Source Type: Journal    
DOI: 10.1021/acsinfecdis.7b00071     Document Type: Article

References (53)

1. Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., and Bartlett, J. (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America Clin. Infect. Dis. 48 (1) 1-12 10.1086/595011
2. World Health Organization. AntimicrobialResistance-Global Report on Surveillance, (2014.
3. Chen, L., Todd, R., Kiehlbauch, J., Walters, M., and Kallen, A. (2017) Notes from the Field: Pan-Resistant New Delhi Metallo-Beta-Lactamase-Producing Klebsiella pneumoniae-Washoe County, Nevada, 2016 MMWR Morb. Mortal. Wkly. Rep. 66 (1) 33 10.15585/mmwr.mm6601a7
4. Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K., Wertheim, H. F., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., Greko, C., So, A. D., Bigdeli, M., Tomson, G., Woodhouse, W., Ombaka, E., Peralta, A. Q., Qamar, F. N., Mir, F., Kariuki, S., Bhutta, Z. A., Coates, A., Bergstrom, R., Wright, G. D., Brown, E. D., and Cars, O. (2013) Antibiotic resistance-the need for global solutions Lancet Infect. Dis. 13 (12) 1057-1098 10.1016/S1473-3099(13)70318-9
5. O'Neill, J. Review on AMR. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations; Wellcome Trust: 2014.
6. Goff, D. A., Kullar, R., Goldstein, E. J., Gilchrist, M., Nathwani, D., Cheng, A. C., Cairns, K. A., Escandon-Vargas, K., Villegas, M. V., Brink, A., van den Bergh, D., and Mendelson, M. (2017) A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail Lancet Infect. Dis. 17 (2) e56-e63 10.1016/S1473-3099(16)30386-3
7. Tommasi, R., Brown, D. G., Walkup, G. K., Manchester, J. I., and Miller, A. A. (2015) ESKAPEing the labyrinth of antibacterial discovery Nat. Rev. Drug Discovery 14 (8) 529-542 10.1038/nrd4572
8. Martens, E. and Demain, A. L. (2017) The antibiotic resistance crisis, with a focus on the United States J. Antibiot. 70, 520 10.1038/ja.2017.30
9. Ventola, C. L. (2015) The antibiotic resistance crisis: part 1: causes and threats P&T Community 40 (4) 277-283
10. Payne, D. J., Gwynn, M. N., Holmes, D. J., and Pompliano, D. L. (2007) Drugs for bad bugs: confronting the challenges of antibacterial discovery Nat. Rev. Drug Discovery 6 (1) 29-40 10.1038/nrd2201
11. Brown, E. D. and Wright, G. D. (2016) Antibacterial drug discovery in the resistance era Nature 529 (7586) 336-343 10.1038/nature17042
12. Bax, R. and Green, S. (2015) Antibiotics: the changing regulatory and pharmaceutical industry paradigm J. Antimicrob. Chemother. 70 (5) 1281-1284 10.1093/jac/dku572
13. Cox, G., Sieron, A., King, A. M., De Pascale, G., Pawlowski, A. C., Koteva, K., and Wright, G. D. (2017) A Common Platform for Antibiotic Dereplication and Adjuvant Discovery Cell Chem. Biol. 24 (1) 98-109 10.1016/j.chembiol.2016.11.011
14. Wright, G. D. (2016) Antibiotic Adjuvants: Rescuing Antibiotics from Resistance Trends Microbiol. 24 (11) 862-871 10.1016/j.tim.2016.06.009
15. Pieren, M. and Tigges, M. (2012) Adjuvant strategies for potentiation of antibiotics to overcome antimicrobial resistance Curr. Opin. Pharmacol. 12 (5) 551-5555 10.1016/j.coph.2012.07.005
16. Hartzell, J. D., Neff, R., Ake, J., Howard, R., Olson, S., Paolino, K., Vishnepolsky, M., Weintrob, A., and Wortmann, G. (2009) Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center Clin. Infect. Dis. 48 (12) 1724-1728 10.1086/599225
17. Rasko, D. A. and Sperandio, V. (2010) Anti-virulence strategies to combat bacteria-mediated disease Nat. Rev. Drug Discovery 9 (2) 117-128 10.1038/nrd3013
18. Harris, T. L., Worthington, R. J., Hittle, L. E., Zurawski, D. V., Ernst, R. K., and Melander, C. (2014) Small Molecule Downregulation of PmrAB Reverses Lipid A Modification and Breaks Colistin Resistance ACS Chem. Biol. 9 (1) 122-127 10.1021/cb400490k
19. Palmer, A. C. and Kishony, R. (2013) Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance Nat. Rev. Genet. 14 (4) 243-248 10.1038/nrg3351
20. Mitchison, D. and Davies, G. (2012) The chemotherapy of tuberculosis: past, present and future Int. J. Tuberc Lung Dis 16 (6) 724-732 10.5588/ijtld.12.0083
21. Fischbach, M. A. (2011) Combination therapies for combating antimicrobial resistance Curr. Opin. Microbiol. 14 (5) 519-523 10.1016/j.mib.2011.08.003
22. Tamma, P. D., Cosgrove, S. E., and Maragakis, L. L. (2012) Combination therapy for treatment of infections with gram-negative bacteria Clin Microbiol Rev. 25 (3) 450-70 10.1128/CMR.05041-11
23. Petrosillo, N., Ioannidou, E., and Falagas, M. E. (2008) Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies Clin. Microbiol. Infect. 14 (9) 816-827 10.1111/j.1469-0691.2008.02061.x
24. Drawz, S. M., Papp-Wallace, K. M., and Bonomo, R. A. (2014) New beta-lactamase inhibitors: a therapeutic renaissance in an MDR world Antimicrob. Agents Chemother. 58 (4) 1835-1846 10.1128/AAC.00826-13
25. Papp-Wallace, K. M. and Bonomo, R. A. (2016) New beta-Lactamase Inhibitors in the Clinic Infect Dis Clin North Am. 30 (2) 441-464 10.1016/j.idc.2016.02.007
26. Drawz, S. M. and Bonomo, R. A. (2010) Three decades of beta-lactamase inhibitors Clin Microbiol Rev. 23 (1) 160-201 10.1128/CMR.00037-09
27. Bush, K. (2015) A resurgence of beta-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens Int. J. Antimicrob. Agents 46 (5) 483-493 10.1016/j.ijantimicag.2015.08.011
28. King, A. M., Reid-Yu, S. A., Wang, W., King, D. T., De Pascale, G., Strynadka, N. C., Walsh, T. R., Coombes, B. K., and Wright, G. D. (2014) Aspergillomarasmine A overcomes metallo-beta-lactamase antibiotic resistance Nature 510 (7506) 503-506 10.1038/nature13445
29. Ramirez, M. S. and Tolmasky, M. E. (2010) Aminoglycoside modifying enzymes Drug Resist. Updates 13 (6) 151-71 10.1016/j.drup.2010.08.003
30. Labby, K. J. and Garneau-Tsodikova, S. (2013) Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections Future Med. Chem. 5 (11) 1285-1309 10.4155/fmc.13.80
31. Wright, G. D. (2005) Bacterial resistance to antibiotics: enzymatic degradation and modification Adv. Drug Delivery Rev. 57 (10) 1451-1470 10.1016/j.addr.2005.04.002
32. Maravic, G. (2004) Macrolide resistance based on the Erm-mediated rRNA methylation Curr. Drug Targets: Infect. Disord. 4 (3) 193-202 10.2174/1568005043340777
33. Sun, J., Deng, Z., and Yan, A. (2014) Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations Biochem. Biophys. Res. Commun. 453 (2) 254-267 10.1016/j.bbrc.2014.05.090
34. Blair, J. M., Webber, M. A., Baylay, A. J., Ogbolu, D. O., and Piddock, L. J. (2015) Molecular mechanisms of antibiotic resistance Nat. Rev. Microbiol. 13 (1) 42-51 10.1038/nrmicro3380
35. Livermore, D. M. (1990) Antibiotic uptake and transport by bacteria Scand. J. Infect. Dis. Suppl. 74, 15-22
36. Lambert, P. A. (2002) Cellular impermeability and uptake of biocides and antibiotics in Gram-positive bacteria and mycobacteria J. Appl. Microbiol. 92 (Suppl.) 46S-54S 10.1046/j.1365-2672.92.5s1.7.x
37. Stokes, J. M., MacNair, C. R., Ilyas, B., French, S., Cote, J. P., Bouwman, C., Farha, M. A., Sieron, A. O., Whitfield, C., Coombes, B. K., and Brown, E. D. (2017) Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance Nat. Microbiol 2, 17028 10.1038/nmicrobiol.2017.28
38. Zabawa, T. P., Pucci, M. J., Parr, T. R., Jr., and Lister, T. (2016) Treatment of Gram-negative bacterial infections by potentiation of antibiotics Curr. Opin. Microbiol. 33, 7-12 10.1016/j.mib.2016.05.005
39. Boudreau, M. A., Fishovitz, J., Llarrull, L. I., Xiao, Q. B., and Mobashery, S. (2015) Phosphorylation of BlaR1 in Manifestation of Antibiotic Resistance in Methicillin-Resistant Staphylococcus aureus and Its Abrogation by Small Molecules ACS Infect. Dis. 1 (10) 454-459 10.1021/acsinfecdis.5b00086
40. Alam, M. K., Alhhazmi, A., DeCoteau, J. F., Luo, Y., and Geyer, C. R. (2016) RecA Inhibitors Potentiate Antibiotic Activity and Block Evolution of Antibiotic Resistance Cell Chem. Biol. 23 (3) 381-391 10.1016/j.chembiol.2016.02.010
41. Worthington, R. J., Blackledge, M. S., and Melander, C. (2013) Small-molecule inhibition of bacterial two-component systems to combat antibiotic resistance and virulence Future Med. Chem. 5 (11) 1265-1284 10.4155/fmc.13.58
42. Worthington, R. J., Richards, J. J., and Melander, C. (2012) Small molecule control of bacterial biofilms Org. Biomol. Chem. 10 (37) 7457-74 10.1039/c2ob25835h
43. Brackman, G., Breyne, K., De Rycke, R., Vermote, A., Van Nieuwerburgh, F., Meyer, E., Van Calenbergh, S., and Coenye, T. (2016) The Quorum Sensing Inhibitor Hamamelitannin Increases Antibiotic Susceptibility of Staphylococcus aureus Biofilms by Affecting Peptidoglycan Biosynthesis and eDNA Release Sci. Rep. 6, 20321 10.1038/srep20321
44. Alipour, M., Suntres, Z. E., and Omri, A. (2009) Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa J. Antimicrob. Chemother. 64 (2) 317-325 10.1093/jac/dkp165
45. Cramer, G. W. and Bosso, J. A. (1996) The role of dornase alfa in the treatment of cystic fibrosis Ann. Pharmacother 30 (6) 656-661 10.1177/106002809603000614
46. Lewis, K. (2007) Persister cells, dormancy and infectious disease Nat. Rev. Microbiol. 5 (1) 48-56 10.1038/nrmicro1557
47. Ejim, L., Farha, M. A., Falconer, S. B., Wildenhain, J., Coombes, B. K., Tyers, M., Brown, E. D., and Wright, G. D. (2011) Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy Nat. Chem. Biol. 7 (6) 348-350 10.1038/nchembio.559
48. Taylor, P. L., Rossi, L., De Pascale, G., and Wright, G. D. (2012) A Forward Chemical Screen Identifies Antibiotic Adjuvants in Escherichia coli ACS Chem. Biol. 7 (9) 1547-1555 10.1021/cb300269g
49. Chong, C. R. and Sullivan, D. J., Jr. (2007) New uses for old drugs Nature 448 (7154) 645-646 10.1038/448645a
50. Gallagher, L. A., Shendure, J., and Manoil, C. (2011) Genome-scale identification of resistance functions in Pseudomonas aeruginosa using Tn-seq MBio 2 (1) e00315-10 10.1128/mBio.00315-10
51. Lee, S. H., Jarantow, L. W., Wang, H., Sillaots, S., Cheng, H., Meredith, T. C., Thompson, J., and Roemer, T. (2011) Antagonism of chemical genetic interaction networks resensitize MRSA to beta-lactam antibiotics Chem. Biol. 18 (11) 1379-1389 10.1016/j.chembiol.2011.08.015
52. Gao, F., Yan, X., Shakya, T., Baettig, O. M., Ait-Mohand-Brunet, S., Berghuis, A. M., Wright, G. D., and Auclair, K. (2006) Synthesis and structure-activity relationships of truncated bisubstrate inhibitors of aminoglycoside 6′-N-acetyltransferases J. Med. Chem. 49 (17) 5273-5281 10.1021/jm060732n
53. Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., Leger, R., Hecker, S., Watkins, W., Hoshino, K., Ishida, H., and Lee, V. J. (2001) Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy Antimicrob. Agents Chemother. 45 (1) 105-116 10.1128/AAC.45.1.105-116.2001